- Release Date: 15/09/14 12:17
- Summary: GENERAL: NZR: Independent Review of Processing Arrangements
- Price Sensitive: No
- Download Document 3.61KB
NZR 15/09/2014 12:17 GENERAL REL: 1217 HRS The New Zealand Refining Company Limited GENERAL: NZR: Independent Review of Processing Arrangements Refining NZ has today published the findings of the latest independent review into the Company's processing arrangements with its customers, completed by Hale and Twomey. The Company's processing arrangements are reviewed annually by the Independent Directors and Refining NZ management to ensure the arrangements remain fit for purpose and are fair to all shareholders, while the Independent Directors periodically commission an independent third party to review the arrangements. This is the third independent review in five years with the previous two carried out by oil industry experts, IHS Energy (formerly Purvin and Gertz). Hale and Twomey were engaged by Refining NZ's Independent Directors to assess the following: - If the current processing agreements provide Refining NZ shareholders with an appropriate financial return, and - Whether the company provides a competitive supply of product to its customers over the business cycle, and - If the benchmarks and associated premiums for valuing crude and product in the processing fee calculation are appropriate, and - If the current fee structure is the most suitable in comparison to the alternatives available. In summary, the Hale and Twomey report made the following conclusions: - Over a 10-year period Refining NZ has provided its shareholders with an appropriate return (i.e. a return with a margin above the weighted average cost of capital (WACC)); - Over a 10-year period Refining NZ has provided its customers with a competitive supply of products (i.e. better than the import equivalent); - During periods when refining margins are low (including the current period), Refining NZ's return is under WACC and the supply to customers is not competitive; - The benchmarks used for crude and product values in the fee calculation are appropriate although freight benchmarks that better reflect actual market costs in the region have become available. With respect to the processing fee structure, Hale and Twomey considered four alternative models to the current arrangements: fixed fee or regulated return; part fixed fee/part variable fee; netback model and merchant refining. Hale and Twomey reported, "The current processing fee structure and split of gross refining margin provides an appropriate balance between Refining NZ's return and customer competitiveness. Alternative structures are unlikely to provide the same balance and alignment, therefore would not prove to be sustainable over the typical business cycle for refineries." A full copy of the Hale & Twomey report is attached to this release and is also available to shareholders via the Refining NZ's website at www.refiningnz.com. ENDS Notes to Editors: The current processing arrangements came into play in 1995 and are intended to provide Refining NZ sufficient funds for investment in the business while giving customers sufficient incentive to utilise the refinery's operations. Hale & Twomey Limited. Established in 2001 by principals Richard Hale and Ian Twomey, the energy consultancy provides strategic advice based on a comprehensive understanding of New Zealand and international energy markets. Both partners have held senior executive positions in major multi-national energy companies, in areas including exploration and production, international oil trading, refining and supply. For further information: Greg McNeill Communications and External Affairs Manager T: 09 432 82311 M: 021 873 623 E: [email protected] End CA:00255248 For:NZR Type:GENERAL Time:2014-09-15 12:17:45
- Forums
- NZX - By Stock
- NZR
- Ann: GENERAL: NZR: Independent Review of Processing Arrangements
Ann: GENERAL: NZR: Independent Review of Processing Arrangements
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some